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Abstract 
Malarial hemozoin may play an important role as a target for antimalarial drugs and in disease pathogenesis. A new assay 
for hemozoin was developed in which the hemozoin was separated from cells by filtration. Trophozoites have substantially 
more hemozoin than rings, but there are relatively small differences between chloroquine-sensitive and chloroquine-resistant 
strains. The effects on hemozoin content of chloroquine and artemisinin, two antimalarial drugs, and E64 and Pepstatin A, 
two protease inhibitors, were measured. At concentrations at which hypoxanthine incorporation was unaffected, the 
hemozoin content of rings was decreased by E64, but not by the other three compounds. Artemisinin and Pepstatin A also 
had little effect on the bemozoin content of trophozoites. Chloroquine and E64 inhibited trophozoite hemozoin formation, 
but inhibited hypoxanthine uptake to a similar or greater extent. When either rings or trophozoites were exposed to several 
higher concentrations of chloroquine, hemozoin content was diminished, but significantly less than hypoxanthine uptake. 
Various concentrations of E64, in contrast, inhibited hemozoin production by both rings and trophozoites significantly more 
than hypoxanthine incorporation, suggesting that hemozoin production may be directly affected by E64. 
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1. In t roduc t ion  
Hemozoin, or malaria pigment, is formed from 
heme molecules that are liberated by hemoglobin 
degradation (reviewed in [1] and [2]). Malaria para- 
sites produce large quantities of  hemozoin since they 
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degrade approximately 25% of their host erythro- 
cytes '  hemoglobin [3]. Hemoglobin digestion, which 
occurs in the parasite food vacuole, may require both 
aspartic [4] and cysteine [5] proteases. Released heme 
is incorporated into hemozoin by the newly discov- 
ered enzyme, heine polymerase [6]. 
Hemozoin may play an important role in the 
pathogenesis of  malaria. During the course of  a 
malaria infection, hemozoin is taken up by the reticu- 
loendothelial system. Hemozoin uptake diminishes 
the phagocytic capacity of  macrophages, perhaps as 
a consequence of  H202-mediated release of  iron 
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from hemozoin, and this may cause immunosuppres- 
sion [7,8]. 
Hemozoin may also play an important role in the 
modes of action of chloroquine and artemisinin. The 
synthesis of hemozoin is inhibited by chloroquine in 
cell-free extracts [6], and in both Plasmodium falci- 
parum [9] and Plasmodium berghei [10,11]. Hemo- 
zoin has also been shown to play an important role 
in the mode of action of artemisinin (qinghaosu) 
[12-18]. Intraparasitic heme catalyzes the break- 
down of artemisinin into an organic free radical 
[13-15] which can alkylate both proteins [16,17] and 
heme molecules [18]. 
In this study, the effects of chloroquine and 
artemisinin on hemozoin production were measured 
in order to gain insight into the modes of action of 
these drugs. In addition, we have studied the effects 
of E 64, a cysteine protease inhibitor, and Pepstatin 
A, and aspartic protease inhibitor, on hemozoin pro- 
duction in order to better understand the relative 
importance of the two classes of proteases. 
2. Materials and methods 
2.1. Chemicals and supplies 
Human serum and red cells were purchased from 
Interstate Blood Bank (Memphis, TN). Tritiated hy- 
poxanthine (1-5 Ci mmo1-1) was purchased from 
Amersham Corp. (Arlington Heights, IL). RPMI 1640 
was purchased from Gibco/BRL (Grand Island, NY). 
All other chemicals were purchased from Sigma 
Chemical Co. (St Louis, MO) unless otherwise noted. 
2.2. Parasites 
brown-black layer at the top of the cell suspension 
after centrifugation. Cultures were used only if they 
contained 95-98% of either mature trophozoites 
(26-32 h) or small rings (12-18 h), the stages 
defined as described by Silamut and White [21]. Host 
cell-free parasites were obtained by saponin lysis 
[22]. Parasitemia and parasite morphology were de- 
termined microscopically from Giemsa-stained thin 
blood films, counting at least 500 erythrocytes. 
2.3. Determination of hemozoin content 
Parasite hemozoin content was assayed as fol- 
lows. Isolated parasites were washed 4 times in 20 
volumes of a Triton X-100 solution (0.05% in water), 
centrifuging in a microfuge at 14000 × g for 5 min 
each time. The final pellet was resuspended in 1 ml 
of 0.05% Triton X-100, and placed in a Branson 
sonicating water bath for 10-20 s in order to fully 
suspend the pellet. The suspension was then taken up 
in a 5-ml syringe and passed through a 25-mm 
diameter 0.45-micron Metricel membrane filter (Gel- 
man Sciences Inc., Ann Arbor MI) and washed by 
passing 1 ml of 0.05% Triton X-100 through the 
filter. Retained hemozoin was assayed by a modifica- 
tion of the pyridine hemochromogen assay [23]. 
Heme was solubilized by placing the filter in 3 ml of 
a reaction mixture containing 1 N KOH/pyr id ine /  
distilled water (1:2:8) and vortexing for 1-2 min. 1 
ml of this solution was put into each of 2 cuvettes. A 
few crystals of sodium dithionite were added to one 
cuvette and 10 p,1 of 50 mM potassium ferricyanide 
to the other, and heme was quantitated by the differ- 
ence in A560 as measured on a Milton Roy Spec- 
tronic 2000 spectrophotometer using reagent hemin 
as a standard. 
P. falciparum strains D6 (chloroquine-sensitive) 
and W2 (chloroquine-resistant) were kindly provided 
by R. Miller, Walter Reed Army Institute of Re- 
search, Washington DC. P. falciparum strain FCR3 
was the gift of M. Perkins, Rockefeller University, 
New York. Parasitized red cells were cultivated by to 
the method of Trager and Jensen [19]. Synchroniza- 
tion by sorbitol lysis [20] was performed for at least 
3 consecutive cycles before parasites were used. 
Every synchronization was followed by careful re- 
moval of cell and hemozoin debris which is the 
2.4. Validation of assay 
To test the validity of this assay, known quantities 
of unpolymerized heme and synthetic polymerized 
/3-hematin were assayed. Unpolymerized heme (10 
mM in 0.02 N NaOH/ethanol, 1:1) [24] and poly- 
merized /3-hematin [25] were prepared and filtered. 
The heme content of the retentate was assayed as 
above. The filtrate was concentrated on a Speedvac 
(Savant, Farmingdale NY) and then assayed for heme 
by pyridine hemochromogen [23]. 
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As a second test of the validity of the assay, the 
hemozoin content of identical aliquots of isolated 
parasites were assayed simultaneously by both the 
method described above and the method of Slater et 
al. [251. 
As a third test for validity, we determined whether 
the hemozoin content of samples was proportional to 
parasitemia. To do this, a suspension of trophozoite- 
infected erythrocytes (10% parasitemia, 50% hemat- 
ocrit) was 2-fold serially diluted with a suspension of 
uninfected erythrocytes (50% hematocrit). 200 Ixl of 
each parasite suspension was then lysed by saponin 
and assayed for hemozoin content as described above. 
As a fourth test for validity, isolated parasite 
suspensions were divided in half and filtered on two 
identical filters. The hemozoin content of one was 
assayed as above. The hemoglobin content of the 
duplicate filter was assayed [26], and expressed as a 
molar percentage of the hemozoin heme content. 
2.5. The effects o f  inhibitors on hemozoin content 
and hypoxanthine incorporation 
To study the effects of antimalarials and protease 
inhibitors on hemozoin synthesis, 10-ml cultures of 
P. falciparum (D 6 strain), at either mature tropho- 
zoite or small ring stage, were incubated in the 
presence of 0.5/xM chloroquine, 0.5/.tM artemisinin, 
50 p,M E64, 50 /.LM of pepstatin A or no addition. 
Immediately after addition of the drugs, 0.2 ml of 
each treated culture was transferred to a well in a 
microtiter plate to which 0.5 /,tCi of [3H]hypo- 
xanthine was then added. Hypoxanthine uptake was 
used to monitor nucleic acid biosynthesis as a gen- 
eral indicator of parasite viability [27,28]. The cul- 
tures and microtiter plates were incubated in a candle 
jar for 6 h at 37°C. The hemozoin content of the 
culture plate was determined as described above. The 
microtiter plate was harvested using a Brandel Cell 
Harvester Model M24 (Brandel, Gaithersburg, MD). 
Filters were counted on a Beckman LS 7000 Scintil- 
lation counter (Beckman Instrument, Fullerton, CA) 
using Scinti-Verse BD (Fisher Scientific, Fair Lawn, 
N J) as scintillant. Infected erythrocytes from the 
same cultures incubated in the absence of inhibitors 
were used as controls. Concentration-response exper- 
iments were also undertaken for chloroquine and 
E64. P. falciparum (D 6 strain) was incubated in the 
Table 1 
Distribution of heme after filtration 
Unpolymerized /3-hematin 
heme 
Retentate (nmol) 13.0 + 0.4 390.3 + 19 
Filtrate (nmol) 978 -I- 42 14.5 + 4.1 
Percent retained on filter paper 1.3 96.5 
Data shown are means + S.D. of triplicate experiments. 
presence of various concentrations of either inhibitor. 
Trophozoite-infected cells were treated exactly as 
above, assaying for both hemozoin content and hy- 
poxanthine incorporation. In order to increase sensi- 
tivity, the ring-infected erythrocytes used for the 
concentration-response curve were incubated as 
above, but for 24 h instead of 6 h. Statistical analy- 
ses of results were performed using two-tailed un- 
paired t-tests (Statview II, Abacus Concepts, Moun- 
tainview, CA). 
3. Results 
3.1. Validation o f  assay 
The filter retains almost no unpolymerized heme 
but nearly all of the synthetic fl-hematin. As shown 
in Table 1, 96% of synthetic fl-hematin was cap- 
tured on the filter paper, while only 1.3% of unpoly- 
merized heme was retained. Thus, polymerized heme, 
but not monomeric heme, is trapped on the filter, 
while monomeric heme, not polymerized heme, can 
be found in the filtrate. 
The filtration assay is effective for measuring 
hemozoin in P. falciparum-infected erythrocytes. 
When isolated parasite suspensions were filtered and 
assayed in parallel by both pyridine hemochromogen 
and Drabkin's reagent, only 1.52 5- 0.7% (N = 4) of 
the retained heme was found to be hemoglobin- 
bound. Furthermore, as expected, the hemozoin con- 
tent was found to vary linearly with parasitemia (Fig. 
1; r 2 = 0.99). 
The filtration method described here agrees well 
with the method of Slater et al. [25]. When different 
preparations of isolated parasites were assayed by 
both methods, and the two methods were plotted 
against each other, there was a very strong correla- 
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Fig. 1. Correlation between parasitemia and hemozoin content in 
trophozoite-infected erythrocytes. Error bars represent standard 
deviations of triplicate experiments. 
tion (Fig. 2), with a slope of 0.999 and an r 2 of 
0.998. 
3.2. Hemozoin content in chloroquine-sensitive and 
chloroquine-resistant strains of  P. falciparum 
A marked difference was found in the hemozoin 
content of trophozoites and rings (Table 2). Tropho- 
Table 2 
Hemozoin contents of infected and uninfected red ceils 
Cell type pmol (10 6 cells) "l 
Uninfected red cells 1.0 -1- 0.3 
Chloroquine-sensitive (Dt). 74.6-t- 5.7 
ring stage 
Chloroquine-seusitive (1:)6)- 637 + 91 
trophozoite stage 
Chloroquine-resistant (FCR 3)- 781 + 25 
trophozoite stage 
Chloroquine-resistant (W 2). 9525- 78 
trophozoite stage 
Data shown are means :1: S.D. of triplicate experiments. 
zoites of D 6 strain contain 637 5- 91 pmol of hemo- 
zoin-heme (106 parasitized cells)- 1 ,  eight times more 
than rings, which contain only 74.6 + 9.7 pmol (10  6 
parasitized cells) -1. In contrast, negligible amounts 
of hemozoin were found in uninfected red cells 
(1.0 5- 0.3 pmol (106 cells)-1). 
The hemozoin contents of three strains were com- 
pared. The three strains had been synchronized si- 
multaneously and appeared by microscopy to be 
trophozoites of the same stage of maturation. Slightly 
more hemozoin was found in the chloroquine-re- 
sistant strains W2 and FCR3 (952 -t- 79 and 781 5- 25 
pmol [106 parasitized cells] -1, respectively) than the 
chloroquine-sensitive, D 6 strain (637 + 91). 
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Fig. 2. Hemozoin content at various parasitemias measured by the 
method of Slater et al. [25] (y-axis) and the filtration method 
described here (x-~is). 
3.3. Effects o f  antimalarials and protease inhibitors 
on hemozoin production and hypoxanthine uptake 
Hypoxanthine uptake and hemozoin production 
were measured in cultures containing synchronized 
small rings (Fig. 3A) or mature trophozoites (Fig. 
3B), incubated in the presence of 0.5 /zM chloro- 
qulne, 0.5 / tM artemisinin, 50 /xM E64, or 50 /zM 
Pepstatin A. None of the compounds affected hypox- 
anthine uptake in rings. Hemozoin production by 
rings was inhibited by E64 (27%) but was unaffected 
by the other compounds. The difference between the 
effect of E64 on hypoxanthine uptake and hemozoin 
content was statistically significant (P--0 .004) .  In 
contrast, all of the compounds caused substantial 
decreases in hypoxanthine uptake by trophozoites 
(30-65%). E64 is the only compound that inhibited 
hemozoin production in trophozoites (37%) more 
than hypoxanthlne uptake (31%), but this difference 
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was not statistically significant. The other three com- 
pounds, chloroquine, artemisinin, and Pepstatin A, 
inhibited hemozoin production in trophozoites (10- 
30%) to a much lesser extent than they inhibited 
hypoxanthine uptake (60-65%) (P  = 0.002, 0.0006, 
and 0.0002, respectively). 
In order to further define the effects of E64 and 
chloroquine on hemozoin production, concentration- 
response curves were performed for hemozoin pro- 
duction and hypoxanthine uptake in both rings and 
trophozoites. At 2, 4, 20 and 100 nM, chloroquine 
inhibited hemozoin production in trophozoites signif- 






0.0004, 0.0001, and 0.0003, respectively) (Fig. 4B). 
For rings (Fig. 4A), chloroquine inhibited hemozoin 
production less than hypoxanthine uptake at concen- 
trations of 10, 20, and 100 nM (P  = 0.0006, 0.003, 
and 0.002, respectively). The differences in the ef- 
fects of chloroquine on hemozoin production and 
hypoxanthine uptake were quite substantial at some 
concentrations. For example, at 10 nM, chloroquine 
inhibited ring hemozoin production by only 14% 
while it inhibited hypoxanthine uptake by 79%. Sim- 
ilarly, trophozoite hemozoin production was only 
inhibited 34-37% at 20 and 100 nM chloroquine 
while hypoxanthine uptake was inhibited by 79-80%. 
E64 had the opposite effect and inhibited parasite 
hemozoin production to a greater extent than hypox- 
anthine uptake for both rings (Fig. 4C) and tropho- 
zoites (Fig. 4D). The differences were statistically 
significant for trophozoites at 13, 25, 50, and 100 
/~M (P  = 0.015, 0.02, 0.03, and 0.04, respectively) 
and for rings at 5 and 25/~M (P  = 0.007, and 0.014, 
respectively). The effects are most marked in rings 
treated with 5 /zM and 25/xM E64, where hemozoin 
production was inhibited by 33% and 46%, while 
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Fig. 3. Inhibition of bypoxanthine uptake (hatched bars) and 
hemozoin production (solid bars) in parasitized erythrocytes carry- 
ing rings (top) and trophozoites (bottom) by 0.5 /~M chloroquine 
(A), 0.5 /zM anemisinin (B), 50 /.tM E64 (C), and 50 /.tM 
pcpstatin A (D). Triplicate cultures were incubated for 6 h and 
data are expressed as % of control untreated cultures. Shown are 
means 5- standard deviations. 
In this study, we have developed a rapid filtration 
assay for malarial hemozoin, and used it to study 
whether chloroquine, artemisinin, Pepstatin A, or 
E64 affect parasite hemozoin production. The effects 
of these compounds on hemozoin production were 
compared with their effects on hypoxanthine incor- 
poration. Chloroquine, artemisinin and Pepstatin A, 
an aspartic protease inhibitor, affect hemozoin pro- 
duction to the same extent or less than hypoxanthine 
incorporation. In contrast, E64, a cysteine protease 
inhibitor, inhibits hemozoin production more than 
hypoxanthine uptake. 
Malarial hemozoin consists of a large polymer, 
containing heine molecules linked to each other by 
bonds between ferric ions and carboxylate oxygens 
[25]. Because of the particulate nature of bemozoin, 
we used a 0.45-/zm filter to separate hemozoin heine 
from soluble hemoglobin-bound or free heme. The 
filters were found to retain > 96% of synthetic 
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/3-hematin but only 1% of unpolymerized heme (Ta- 
ble 1). Hemozoin isolated in this manner from in- 
fected red cells contained only about 1% 
hemoglobin-bound heme. Furthermore, uninfected 
red cells were found to contain < 2% as much 
filterable heme as ring-infected red cells. Thus, the 
assay is relatively specific for hemozoin (Table 2). 
Also, a linear correlation was found between para- 
sitemia and hemozoin content (Fig. 1). Thus, the 
assay is sensitive enough to measure hemozoin in 
100 /zl of packed red blood cells containing tropho- 
zoites at a 1% parasitemia (Fig. 1). 
As added evidence for the validity of the filtration 
assay, a good correlation was found between this 
assay method and a previously published method 
(Fig. 2). Furthermore, the quantities of hemozoin 
reported here are similar to those reported by others. 
For example, the amounts of hemozoin reported by 
Orjih and Fitch [9] in rings (27-50 pmol [106 
cells] -1) and trophozoites (515-960 pmol [106 
cells] -1) are very comparable to those shown in 
Table 1. In addition, since the mean corpuscular 
hemoglobin of normal red cells is 29 + 2 pg [29], 
106 red cells contain approximately 1800 pmol of 
hemoglobin heme, and our data therefore suggest 
that the hemozoin of mature trophozoites contains 
35-52% of the heme originally found in hemoglobin 
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Fig. 4. Concentration-response curves of hemozoin production (C)) and hypoxanthine uptake (0) in ring-infected erythrocytes by 
chloroquine (A) and E64 (C) and in trophozoite-infected erythtocytes by chloroquine (B) and E64 (D). Triplicate ring-infected and 
trophozoite-infected cultures were incubated 24 h and 6 h, respectively. Shown are means + standard deviations. 
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that 25% of hemoglobin in an infected cell is de- 
graded [3]. 
The content of hemozoin in trophozoites is 8-fold 
higher than in rings (Table 2). This is not surprising 
since hemozoin is usually only observed by light 
microscopy in trophozoites. The hemozoin content of 
the ring stage might, in reality, be even lower, since 
the synchronized cultures of rings contained 2-5% 
trophozoites. However, it is also possible that 
hemoglobin degradation may have already started, 
since the ring stages used in this experiment repre- 
sent 12-16 h of development. 
The hemozoin content of the chloroquine-sensi- 
tive strain, D6, at the mature trophozoite stage was 
slightly lower than that of the chloroquine-resistant 
strains (W2 and FCR-3) (Table 1). This is not consis- 
tent with the findings of Orjih and Fitch [9] who 
found that HB-3, a chloroquine-sensitive strain of P. 
falciparum, synthesized more fl-hematin than In- 
dochina I /CDC, a chloroquine-resistant strain. Thus 
it is likely that all of the differences are due to 
normal strain variation or to slight differences in the 
stages of development used. In aggregate, however, 
the data suggest that differences in hemozoin content 
between strains may not be associated with chloro- 
quine resistance. 
Chloroquine has been shown to have a number of 
biochemical effects [30-34], including the inhibition 
hemozoin biosynthesis in cell-free extracts [6]. 
Chloroquine-induced decreases of hemozoin content 
have recently been demonstrated in cell culture and 
in vivo [9,10]. But were these decreases in hemozoin 
content a direct result of heme polymerase inhibition 
or a consequence of parasite death due to another 
mechanism? In order to determine this, we set out to 
ascertain whether chloroquine affects hemozoin syn- 
thesis at concentrations at or below those which 
affect parasite viability. 
Hypoxanthine incorporation was used here as an 
indicator of parasite viability. Hypoxanthine is taken 
up rapidly by malaria-infected red cells and incorpo- 
rated into nucleic acid, predominantly RNA [1,35]. 
Hypoxanthine incorporation has been widely used to 
assess the effects of drugs on P. falciparum [27], and 
correlates well with morphological changes [28]. 
In this paper, the effects of chloroquine on hemo- 
zoin production were assayed at concentrations which 
were close to the drug's in vitro 50% inhibitory 
concentration (IC5o). As measured here, hypoxan- 
thine uptake was inhibited by 50% at 3 -6  nM (1.5-3 
ng m1-1) (Fig. 4A and B) which is similar to the 
previously reported IC50 for D 6 strain of P. falci- 
parum (2-7  ng m1-1) [36]. Below the IC50 (1 nM) 
chloroquine has no effect on either hemozoin pro- 
duction nor hypoxanthine uptake in rings and tropho- 
zoites. At the IC50 or higher, hemozoin production is 
inhibited, but to a lesser extent than hypoxanthine 
incorporation. 
These data are not inconsistent with the observa- 
tions of Fitch and colleagues for both P. falciparum 
[9] and P. berghei [10,11]. Decreases in hemozoin 
production by P. falciparum in vitro were only 
observed by these investigators at chloroquine con- 
centrations between 25 and 50 ng ml- l ,  which are 
very much higher than the reported IC50 values for 
chloroquine-sensitive P. falciparum (2-7  ng m1-1) 
[36]. Orjih and Fitch [9] reported no change in 
hemozoin production in cultures exposed to 12.5 ng 
ml-1 (25 nM) chloroquine, which is closer to the 
IC50. Similarly, for P. berghei, diminished heme 
polymerase was only observed in mice treated with 
62 mg kg- 1 chloroquine which is over 12-fold higher 
than the reported EDgo for chloroquine in P. 
berghei-infected mice [37], which is far lower. For 
neither P. falciparum nor P. berghei did these inves- 
tigators assess parasite viability other than by light 
microscopy which is relatively insensitive. There- 
fore, they could not determine whether the effect of 
the drug on hemozoin was greater or smaller than the 
effect of the drug on parasite viability. 
Thus, chloroquine appears to affect hemozoin 
synthesis to a lesser extent than hypoxanthine up- 
take. This does not rule out the possibility that heme 
polymerase is still the target. The possibility exists 
that a small effect of chloroquine on hemozoin 
biosynthesis is sufficient to kill the parasite. The fact 
that chloroquine's effects on hemozoin content are 
only seen at high concentrations is also consistent 
with the possibility that the drug is killing parasites 
by an alternate mechanism and affecting hemozoin 
synthesis secondarily. Thus, there is still the need to 
consider alternate modes of action of this drug [30- 
34]. 
The data presented here also have important im- 
plications for understanding the mode of action of 
artemisinin. We have recently proposed a two-step 
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mechanism of action [16-18]: (1) heme-catalyzed 
activation of artemisinin into a free radical, and (2) 
aikylation of proteins and heme. However, we have 
hitherto been unable to determine whether protein 
alkylation or heme alkylation is more important. If 
heme alkylation were important in vivo, we postu- 
lated that artemisinin treatment might lead to a de- 
crease in parasite hemozoin in either of two ways. 
First, alkylated hemes tend to be unstable and release 
iron [38]; artemisinin treatment might thus cause the 
degradation of hemozoin heme. Second, the 
artemisinin-heme adducts might act as an inhibitor of 
heme polymerase. However, the data presented here 
show that artemisinin treatment does not diminish 
hemozoin content and argue against, but do not rule 
out, the importance of heme as an alkylation target. 
The effects of two protease inhibitors on hemo- 
zoin production were assessed. We initially used 50 
/xM of each, which is higher than the reported IC50s 
(4 and 12 /zM for Pepstatin A and E64, respectively 
[39]). Pepstatin A, a specific aspartic protease in- 
hibitor, did not inhibit hypoxanthine uptake or hemo- 
zoin production in ring-infected erythrocytes. For 
trophozoite-infected erythrocytes, Pepstatin A inhib- 
ited hemozoin production in trophozoites by only 
about 10%, but hypoxanthine incorporation by 
> 60%. This suggests that Pepstatin A may not 
directly inhibit hemozoin production. In contrast, 
E64, a specific cysteine protease inhibitor, inhibits 
hemozoin production more than hypoxanthine uptake 
in both rings and trophozoites at a variety of concen- 
trations. These results imply that E64 directly affects 
hemozoin production, perhaps by inhibiting a cys- 
teine protease involved in hemoglobin degradation 
[5]. These data are consistent with the observations 
of Rosenthal et al. [5], who found that the food 
vacuoles of E64-treated parasites stained more darkly 
than the food vacuoles of untreated parasites, sug- 
gesting the continued presence of undigested 
hemoglobin. The P. falciparum cysteine protease 
has recently been molecularly cloned [40], and may 
therefore offer a promising new target for antimalar- 
ial chemotherapy. 
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